A viral FLIP protein, E8, exogenously-expressed in the mesenchymal lineage of mice leads to bone malformations, lipoatrophy, and muscular atrophy

doi:10.21203/rs.3.rs-4215975/v1

Download PDF

Article

A viral FLIP protein, E8, exogenously-expressed in the mesenchymal lineage of mice leads to bone malformations, lipoatrophy, and muscular atrophy

https://doi.org/10.21203/rs.3.rs-4215975/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

The equine herpesvirus 2 E8 protein is a member of the viral FLIP family, and as such, it is a potent inhibitor of death receptor-induced apoptosis in cultured cells. To extend our study of the effects of E8 to animals, we generated a mouse model in which the progeny of a cross between two transgenic mice conditionally express E8 under the control of the collagen type I α2 chain (Col1α2) promoter, allowing us to monitor and characterize the effects of E8 expression in the mesenchymal cell lineage. We observed growth defects associated with irregular bone formation during development. In addition, adult animals exhibited both lipoatrophy-like and muscular atrophy-like symptoms. These abnormal phenotypes likely arise from incomplete differentiation of mesenchymal stem cells. To examine this hypothesis in more detail, we expressed E8 in the mouse mesenchymal stem line C3H10T1/2 and performed a microarray analysis. Factors such as Nov/CCN3, STEAP4, and Ankrd1/CARP, which are involved in differentiation from mesenchymal stem cells to osteoblasts, adipocytes and myoblasts were affected. Taken together, our results demonstrate that the constitutive expression of herpesvirus gene products in the mesenchymal progenitors affects differentiation into multiple cell lineages.

Biological sciences/Stem cells/Mesenchymal stem cells

Biological sciences/Biotechnology/Animal biotechnology/Genetic engineering

bone formation

lipoatrophy

mesenchymal stem cell

micro CT

muscular atrophy

viral FLIP

Protein-protein interactions are essential for many biological processes and one structural motif that can facilitate these interactions is the α-helix¹. The death domain (DD) superfamily comprises four groups: the DD subfamily, the death effector domain (DED) subfamily, the caspase recruitment domain (CARD) subfamily, and the pyrin domain (PYD) subfamily^2,3. These domains form a structure, containing six α-helices, that engages in protein-protein interactions. Many members of this superfamily function in cell death and inflammation². Among them, the DED subfamily includes 7 proteins: PEA-15, FADD, DEDD, DEDD2, c-FLIP, caspase-8 (Casp8), and caspase-10 (Casp10)⁴. The latter three proteins possess two DED domains in tandem as a prodomain. Both Casp8 and Casp10 are pro-apoptotic, whereas c-FLIP is a negative regulator of these two caspases via homotypic interactions involving the DEDs⁵. In several viruses, proteins containing tandem DEDs were identified and collectively termed viral FLIP (v-FLIP) to distinguish it from cellular FLIP (c-FLIP)^6,7. E8 is a v-FLIP derived from equine herpes virus, and it has been shown to potently inhibit death receptor-mediated apoptosis. It operates by suppressing the pro-apoptotic activity of Casp8 through interactions with their DEDs^8–10. Therefore, it was posited that the ectopic expression of E8 would produce the same effect as the loss of function of Casp8 in the signaling pathway.

We previously showed that Casp8-deficient mice die in utero, with abnormal development of the heart, neural tube, and angiogenesis¹¹. In this study, we generated a transgenic mouse line conditionally expressing E8 and investigated the extent to which E8-expressing mice resemble Casp8-deficient mice. Unexpectedly, we found that E8 expression affects tissues derived from mesenchymal stem cells, suggesting it may disrupt pathways independent of its known regulation of Casp8.

Generation of E8/Cre double transgenic (E8/Cre-DTg) mice

The E8 protein derived from equine herpesvirus contains tandem “death effector domains (DEDs)” termed DED1 and DED2 (Fig. 1A). To establish a transgenic mouse line conditionally expressing E8, we generated a plasmid construct, pCAG-EGFP/FlagE8 consisting of the CAG promoter, floxed EGFP and SV40 polyA, Flag-E8 and rabbit β-globin polyA DNA fragments (Fig. 1B). In the presence of Cre recombinase, the EGFP-SV40 polyA cassette should be excised, allowing the expression of the FlagE8 gene (Fig. 1C). We also constructed plasmid pCS2-FlagE8 to investigate the functional activity of E8 in cultured cells (Fig. 1B). To confirm the Cre-mediated recombination and the expressional change of gene products, we transfected these plasmid DNAs into HeLa cells and analyzed protein extracts from the respective cells by immunoblot analysis (Fig. 1C). A shift from EGFP to FlagE8 was detected when Cre was expressed. It has been shown that E8 prevents cell death mediated through death receptors when exogenously expressed^8–10. We further examined whether E8 has an anti-apoptotic activity for death receptor-mediated stimuli (Fig. S1). In the cell population expressing FlagE8, more red fluorescent-positive cells survived the cell death stimulus compared to the population of cells not expressing FlagE8.

To establish a transgenic mouse line conditionally expressing FlagE8, a DNA fragment containing the CAG:EGFP/FlagE8 transgene cassette was injected into fertilized heterozygous eggs. Five founder mice carrying the transgene were born and exhibited no developmental abnormalities (data not shown). The established five founders were designated “E8-STg” (E8 single transgenic mouse). Among these animals, three mouse sublines, E8-STg (line E), E8-STg (line O), and E8-STg (line U) were selected due to high EGFP expression in the skin of neonatal animals; these were backcrossed onto C57BL/6 mice to ensure genetic background homogeneity (Fig. S2). Thus, we have established transgenic mouse lines carrying the CAG:EGFP/FlagE8 construct.

As we observed irregular development of the fetal heart in Casp8-deficient mice¹¹, we searched for a transgenic mouse line that expresses Cre specifically in tissues including the heart, and chose the Col1α2-Cre transgenic (Tg) mouse line as a candidate. In these animals, as Cre expression is under the control of the promoter/enhancer unit of the col1α2 gene, Cre proteins are synthesized only in the mesenchymal cell lineage in adult animals¹². To establish the transgenic mice conditionally expressing E8 in the mesenchymal lineage, we crossed E8-STg mice with Col1α2-Cre Tg mice. Progeny from a mating of E8-STg females with Col1α2-Cre Tg males were examined for FlagE8 expression at E16.5 by immunohistochemical analysis with an anti-Flag antibody (Fig. 1D and Fig. S3). These staining profiles largely coincided with Cre expression in Col1α2-Cre Tg mice¹². The resulting E8- and Cre-expressing double transgenic mice are referred to as “E8/Cre-DTg” hereafter.

Growth retardation of E8/Cre-DTg mice

Growth of E8/Cre-DTg mice was monitored. They were able to survive beyond 2 years (data not shown). In addition, male and female animals have normal reproductive capacities (data not shown). However, they exhibited growth defects (Fig. 2A). E8/Cre-DTg mice were significantly smaller than E8-STg mice. Body weight of E8/Cre-DTg mice was dramatically decreased compared with that of E8-STg mice (Fig. 2B). Histological analysis revealed no abnormalities in the endoderm-derived tissues such as liver (data not shown). Thus, it is likely that only mesenchymal tissues specifically manifest abnormalities. Taken together, when E8 is expressed in the mesenchymal cell lineage, transgenic animals can survive and reproduce but display some morphological defects.

Skeletal defects in E8/Cre-DTg mice

To investigate in more detail the cause of growth defects in E8/Cre-DTg mice, we focused on bone formation. We stained bone and cartilage of E8/Cre-DTg newborn mice and their littermates (Fig. S4). Skeletal elements of E8/Cre-DTg mice were weak and short compared to those of their single-transgenic littermates, suggesting that the abnormal bone formation has already occurred in neonatal animals. To further examine whether expression of E8 affects postnatal bone formation, we monitored the skeletal architecture of E8/Cre-DTg mice by micro-computed tomography (mCT). It has been shown that skeletal elements form by two distinct processes: endochondral ossification, during which a cartilage template is replaced by bone, and intramembranous ossification, whereby mesenchymal cells differentiate directly into osteoblasts¹³. The bones of the skull are primarily formed by intramembranous ossification. mCT analysis of the skull revealed that the heads of E8/Cre-DTg mice were significantly smaller than those of E8-STg littermates at 20 months of age (Fig. 3A). The length from the tip of the nose to the back of the head in E8/Cre-Tg mice was clearly shorter than that in E8-STg mice. The difference of the length is more noticeable than when they were newborns, showing a reduction in length ratio from 0.9 to 0.81 (Fig. 3A and Fig. S4). Many skeletal elements of E8/Cre-DTg mice were clearly small (Fig. S5). In addition, we found that the calcification is insufficient in the parietal region of E8/Cre-DTg mice (Fig. S5, shown by an arrow). Furthermore, the distal femur and proximal tibia of E8-STg mice and E8/Cre-DTg mice were examined at the ages of 20 months using mCT (Fig. 3B). Compared with E8-STg mice (Fig. 3B, a-c), E8/Cre-DTg mice (Fig. 3B, d-f) were observed to have less trabecular bone loss and osteophyte formation. Histological analysis of femurs also showed that the trabecular bone areas in the epiphysis are substantially lower in 10-month-old E8/Cre-DTg mice compared with E8-STg mice (Fig. 3C). Thus, mCT and histological analyses suggest that expression of E8 partially inhibits bone formation.

Abnormal phenotype in the fat tissues of E8/Cre-DTg mice

E8/Cre-DTg mice are lean as well as small. Lipoatrophy is a known manifestation of a lack of fat accumulation¹⁴. By mCT analysis, we found that E8/Cre-DTg mice exhibit less fat accumulation compared with their E8-STg littermates (Fig. 4A, B). Histological examination verified the small size of adipocytes in the tissues, indicating a lower uptake of fat (Fig. 4C). As adipocytes as well as osteoblasts are derived from mesenchymal stem cells, the lipoatrophy-like phenotype of E8/Cre-DTg mice might be caused by aberrant adipocyte differentiation from stem cells.

Abnormal phenotype in skeletal and cardiac muscles of E8/Cre-DTg mice

We observed a Kyphosis-like symptom in E8/Cre-DTg mice, especially in aged females (Fig. S6, shown by an arrow). By mCT scanning, we noticed that the curve of the spine was due to underdevelopment of the muscles of the back (Fig. 5A). Histological examination confirmed this irregular phenotype. The skeletal muscles in the femur of E8/Cre-DTg mice showed patchy degeneration and atrophy of fascicles (Fig. 5B). Furthermore, cardiomyocytes also showed degeneration and focal fibrosis (Fig. 6). Thus, both skeletal and cardiac muscles, which are differentiated from mesenchymal stem cells, showed abnormalities in E8/Cre-DTg mice.

Establishment and characterization of C3H10T1/2 transfectants expressing E8

Mesenchymal stem cells (MSCs) are highly proliferative and clonogenic cells that are capable of differentiating into a variety of cell types, including osteoblasts, chondrocytes, adipocytes, fibroblasts, and myoblasts¹⁵. The murine cell line C3H10T1/2 has been shown to retain these properties of MSCs¹⁶. Therefore, this cell line is useful for analyzing the effect of E8 expression in cells cultured in vitro. We co-transfected plasmid DNAs which carry the FlagE8 transgene and the neomycin-resistance gene into C3H10T1/2 cells and cultured them in the presence of G418 to remove non-transfected cells. Using microarray analysis, we examined the expression profiles of transcripts from transfected C3H10T1/2-FlagE8 cells, and compared those to transcript profiles of parental C3H10T1/2 cells. The analyzed data was deposited as GSE261470 in the Gene Expression Omnibus (GEO) database. Among 23,471 transcripts examined, 52 transcripts were decreased by more than 4-fold, and 9 transcripts were increased by more than 4-fold in C3H10T1/2-FlagE8 cells (Table S1 and S2). We focused on STEAP4 (Six-Transmembrane Epithelial Antigen of Prostate4), Ankrd1 (Ankyrin repeat domain-containing protein 1)/CARP, and Nov (Nephroblastoma Overexpressed)/CCN3 among the transcripts that changed significantly (Fig. 7). STEAP4 is known as an inducer of adipogenesis¹⁷, and Ankrd1/CARP is involved in cardiogenesis and myogenesis¹⁸. The expression levels of these two transcripts were decreased in C3H10T1/2-FlagE8 cells. In contrast, Nov/CCN3, which is a negative regulator of osteoblastogenesis¹⁹, was highly expressed in C3H10T1/2-FlagE8 cells. Based on a heat map analysis, we suggest that overall, the expression of genes involved in the induction of differentiation are suppressed by E8 expression in mesenchymal stem cells; and by the same token, the expression of suppressive factors is increased by E8 expression (Fig. S7).

We observed that equine herpes virus E8 protein causes growth retardation associated with irregular bone formation, as well as lipoatrophy-like and muscular atrophy-like symptoms when it is expressed in the mesenchymal cell lineages of mice (Fig. 2–6 and Fig. S4-S6). Furthermore, when E8 is expressed in C3H10T1/2 mesenchymal stem cells (MSCs), the expression levels of differentiation-inducing factors are reduced (Fig. 7, Fig. S7, and Tables S1 and S2). Taken together, these results suggest that E8 acts in MSCs or progenitor cells to weaken, but not completely suppress, differentiation.

In our previous study, we generated Casp8-deficient mice¹¹. Homozygous Casp8-deficient mice are embryonic lethal and show abnormalities in the heart and neural tube, as well as defective angiogenesis. Other groups also verified the same phenotype in Casp8-defcient mice²⁰. However, when a necroptosis-inducing protein RIPK3 (Receptor Interacting Protein Kinase 3) was further deleted, Casp8-deficient mice were viable^20,21. It is worth noting that Casp8-RIPK3 double-deficient mice are normal with regard to bones, fat, and muscles, even in adults. This suggests that Casp8 is unrelated to bone formation, adipose formation, and muscle formation. In this study, we revealed that E8, which was previously identified as an inhibitor of Casp8 activation, affects the induction of differentiation from MSCs. Consequently, we propose that E8 interacts with a factor(s) different from Casp8 in MSCs.

E8 is a member of the virus DED-containing protein family, and other members in this family have the ability to activate NF-κB^22,23. Although our results are still preliminary, we detected the activation of NF-κB in E8-expressing C3H10T1/2 cells. Therefore, we explored the possibility that NF-κB is a regulator of multiple lineage differentiation from MSCs. However, it has been shown that suppression of NF-κB activation promotes differentiation of osteoblasts and has an antianabolic effect on bone formation²⁴. In addition, it has been suggested that NF-κB is not involved in myogenesis and adipogenesis^25,26. Therefore, NF-κB is unlikely a main regulator. So far, Runx2 for osteogenesis, Sox9 for chondrogenesis, PPARγ for adipogenesis, and MyoD for myogenesis from MSCs have been identified as representative differentiation factors²⁷. They are cell-lineage specific regulators but not a universal factor. Conceivably, E8 may interact with a master regulator controlling multiple lineage differentiation from MSCs. Binding of E8 to such a factor would then suppress the differentiation-inducing ability.

From a different perspective, E8 might activate or stabilize a factor that suppresses differentiation. Interestingly, E8 has been shown to enhance the Wnt signaling pathway²⁸. Wnt is known to act as an inhibitor of cell fate determination for osteogenesis, chondrogenesis, adipogenesis, and myogenesis²⁹. It will be important to identify E8-interacting proteins or molecules to gain insights on the molecular mechanisms governing the regulation of MSC differentiation. Additionally, our transgenic mice, which have normal lifespans despite these growth abnormalities, are unique and thus useful as a model animal.

Antibodies

Antibodies used for immunodetection were anti-Flag and peroxidase-conjugated anti-Flag (M2, Sigma-Aldrich, St. Louis, MO, USA), anti-GFP (polyclonal, MBL, Nagoya, Japan), anti-actin (MAB1501R, Chemicon International Inc., Temecula, CA, USA), and HRP-conjugated anti-mouse and anti-rabbit IgG (Cell Signaling Technology, Danvers, MA). As a stimulant of apoptotic cell death, an agonistic anti-human Fas antibody (CH11, MBL) was used.

Mice and cultured cells

The transgenic mouse line Col1α2-Cre, which was previously generated¹², expresses a Cre recombinase under the control of the promoter/enhancer of the gene encoding the α2 chain of collagen type I (Col1α2). C57BL/6 and C3H mice were purchased from CLEA Japan Inc. (Tokyo, Japan). All procedures were performed in accordance with the ARRIVE guidelines for the care and use of animals and were approved for five years by the Institutional Animal Care and Use Committee at Kyoto University (Lif-K07002, Lif-K08010, Lif-K09010, Lif-K10010, and Lif-K11010). To maintain the health of the animals, mice were housed with a 12 hr light-dark cycle, with standard humidity (50%) and temperature (23.5°C), and were fed the GLP-compliant and standard diet (CA-1, CLEA Japan, Inc.) specifically designed for rodents. Anaesthesia and euthanasia of mice were performed in accordance with the AVMA Guidelines 2020. The murine mesenchymal stem cell line C3H10T1/2 (ATCC, CCL-226)³⁰ and human cervical carcinoma cell line HeLa (ATCC, CCL-2.2) were cultured in DMEM with 10% fetal calf serum (FCS).

Plasmid constructs

The plasmid construct pCS2-FlagE8 was generated by subcloning a Flag-tagged E8 cassette from pLck-FlagE8³¹ into the pCS2 expression vector. The plasmid construct pCAG-EGFP/FlagE8 was generated with a DNA fragment carrying both EGFP cDNA and an SV40 polyadenylation sequence, which was flanked by two loxP sites, followed by a Flag-E8 DNA fragment from pCS2-FlagE8; the resulting cassette was cloned into the pCAGGS expression vector³². For expression of a Cre recombinase in the cultured cells, the plasmid construct pBS185 (Invitrogen, Carlsbad, CA, USA) was used. For detection of transfected cells, the plasmid construct pCAG-mCherry, which was previously generated³³, was used. The plasmid construct pME18S-Neo, which carries a neomycin resistance gene³⁴, was used for selection of stably transfected cells using G418 disulfate solution (Nacalai Tesque, Kyoto, Japan).

Generation of transgenic mice

In a preliminary study, we failed to generate mice constitutively expressing E8 protein. Therefore, as a next approach, we sought to generate mice conditionally expressing E8. A DNA fragment carrying the CAG:EGFP/FlagE8 transgene from the pCAG-EGFP/FlagE8 plasmid was microinjected into F1 (B6C3-F1) heterozygous eggs from a cross between C57BL/6 and C3H strains, and surviving eggs were transferred into the oviducts of recipient pseudopregnant females, as described previously³⁵. Three transgenic lines expressing EGFP throughout the body were established, and these were backcrossed onto C57BL/6 mice to ensure genetic background homogeneity.

Genotyping

The genotype of transgenic mice carrying the cre gene was confirmed by PCR on mouse tail genomic DNA, using primers (5'-TTAGCACCACGGCAGCAGGAGGTT-3' and 5'-CAGGCCAGATCTCCTGTGCAGCAT-3'). The PCR amplification was performed using KOD-Plus polymerase (TOYOBO, Osaka, Japan) following the manufacturer’s protocol.

Histological and immunohistochemical analyses

Tissues isolated from E8-STg and E8/Cre-DTg mice were fixed in 10% PBS-buffered formalin (Nacalai Tesque), embedded in paraffin wax, cut into 3–4 µm sections, and dewaxed in xylene and ethanol. Bone samples were also decalcified with 10% ethylenediaminetetraacetic acid in 0.2M phosphate buffer (pH7.3) for 21 days at 4°C before paraffin embedding. Tissue specimens were then examined by hematoxylin and eosin (HE) staining and Masson trichrome (MT) staining as described previously³⁶. For immunohistochemical staining, slides were dipped in methanol containing H₂O₂ (0.3% (v/v)) to quench endogenous peroxidase activities for 30 min. After washing with PBS, slides were incubated with a peroxidase-conjugated anti-Flag antibody (10 µg/ml) with microwave irradiation for 15 min and washed with PBS three times for 5 min³⁷. After washing with PBS three times, liquid DAB+ (K3468, DAKO, Carpinteria, CA, USA) was applied, and brown precipitates were visualized. Nuclear counterstaining was done with hematoxylin.

Micro CT analyses

The bone structure integrity and the fat content of E8/Cre-DTg and their littermates were evaluated using a micro computational tomographic scanner (mCT) (R_mCT, Rigaku, Akishima, Japan). The operating conditions of mCT were 90 kV and 120 µA, and the resolution was set to a voxel size range of 20–100 µm for each sample.

Transfection of plasmid DNAs into cultured cells

To ectopically express the transgenes in cultured cells, plasmid DNAs were transiently transfected into cells using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer’s protocol. Typically, two days later, transfectants were examined for cytological analysis, immunoblot analysis. To establish clonal lines, transfected cells were placed under selection with G418 starting two days after transfection.

Immunoblot analyses

To detect FlagE8 and EGFP proteins in cultured cells, HeLa cells were transfected with pCS2, pCS2-FlagE8, or pCAG-EGFP/FlagE8 with or without pBS185, and harvested after two days. Briefly, cells were suspended in lysis buffer [50 mM Tris-HCl (pH 7.5), 20 mM MgCl₂, 0.5% Nonidet P-40, 150 mM NaCl supplemented with protease inhibitor cocktail (Nacali Tesque)]. After removing cell debris by centrifugation, cell lysates were combined with Laemmli’s sample buffer, resolved by SDS-PAGE, and analyzed by immunoblotting with anti-Flag, anti-GFP, and anti-actin antibodies, respectively. After incubation with HRP-conjugated anti-mouse or anti-rabbit IgG antibodies, the bound immune complexes were visualized with Immobilon Western Chemiluminescent HRP Substrate (Millipore Corporation, Billerica, MA, USA) using a luminescent image analyzer (LAS-3000, Fujifilm, Tokyo, Japan).

Establishment of E8-expressing C3H10T1/2 cells

To establish mesenchymal stem cells stably expressing E8, C3H10T1/2 cells were co-transfected with pCS2-FlagE8 and pME18S-Neo plasmids at a 4:1 ratio and selected for G418 resistance. The established Neomycin-resistant cells were termed C3H10T1/2-FlagE8.

Microarray analysis

For the Oligo DNA microarray analysis, parental C3H10T1/2 cells and C3H10T1/2-FlagE8 cells were cultured in parallel, and total RNAs were extracted from these two-type cells using Sepasol solution, following the manufacturer’s protocol (Nacalai Tesque). Microarray analysis was performed with a 3D-Gene Mouse Oligo chip 24k system (Toray Industries Inc., Tokyo, Japan). Briefly, total RNAs were labeled with Cy5 for parental C3H10T1/2 or Cy3 for C3H10T1/2-E8, using an Amino Allyl MessageAMP II aRNA Amplification Kit (Applied Biosystems, Waltham, MA, USA). The Cy5- or Cy3-labeled aRNA pools were mixed with hybridization buffer. The hybridization was performed according to the manufacturer's protocol (https://www.3d-gene.com). The hybridization signals were obtained with a 3D-Gene Scanner (Toray Industries Inc.), and processed by 3D-Gene Extraction software (Toray Industries Inc.). Detected signals for each gene were normalized by a global normalization method, with the median Cy3/Cy5 ratio adjusted to 1. The analyzed data was deposited in the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261470).

Statistical analysis

The statistical data are presented as the mean and standard deviation. Differences were assessed using Student’s t-test. Statistically significant differences (P < 0.05 and P < 0.01) are indicated in the figures.

Author Contribution

K.S. established the double transgenic mouse line, prepared figures and wrote the main manuscript text, N.Y. has generated the E8-carrying transgenic mouse line, Y.O. and S.T. performed histological and immunohistological analyses, T.T. and S.T. analyzed the bone histologically, Y.O. examined mice with a microCT. All authors reviewed the manuscript.

Acknowledgement

We are grateful to Peter Angel (DKFZ Heidelberg), Chisa Shukunami (Hiroshima University), and Junichi Miyazaki (Osaka University) for providing Col1α2-iCre mouse, C3H10T1/2 cell line, and pCAGGS expression vector, and thank Shu-ichi Yamada, Nobuaki Misawa, and James A. Hajna for technical assistance for generation of transgenic mice, the technical assistance of the preparation of tissue sections, and critical reading. This work was supported in part by JSPS Kakenhi (JP16H06276 [AdAMS (Aa210038)]) to ST.

Data Availability

The analyzed data was deposited as GSE261470 in the Gene Expression Omnibus (GEO) database. The URL address on the analyzed data in the GEO database was described in the Materials and methods section of the manuscript (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261470).

Edwards, T. A. & Wilson, A. J. Helix-mediated protein–protein interactions as targets for intervention using foldamers. Amino Acids 41, 743–754 (2011).
Park, H. H. et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25, 561–586 (2007).
Kersse, K., Verspurten, J., Vanden Berghe, T. & Vandenabeele, P. The death-fold superfamily of homotypic interaction motifs. Trends Biochem. Sci. 36, 541–552 (2011).
Valmiki, M. G. & Ramos, J. W. Death effector domain-containing proteins. Cell. Mol. Life Sci. 66, 814–830 (2009).
Tibbetts, M. D., Zheng, L. & Lenardo, M. J. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4, 404–409 (2003).
Thome, M. & Tschopp, J. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1, 50–58 (2001).
Li, F. Y., Jeffrey, P. D., Yu, J. W. & Shi, Y. Crystal structure of a viral FLIP: insights into FLIP-mediated inhibition of death receptor signaling. J. Biol. Chem. 281, 2960–2968 (2006).
Bertin, J. et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. U S A 94, 1172–1176 (1997).
Hu, S., Vincenz, C., Buller, M. & Dixit, V. M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621–9624 (1997).
Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517–521 (1997).
Sakamaki, K. et al. Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ. 9, 1196–1206 (2002).
Florin, L. et al. Cre recombinase-mediated gene targeting of mesenchymal cells. Genesis 38, 139–144 (2004).
Eames, B. F., de la Fuente, L. & Helms, J. A. Molecular ontogeny of the skeleton. Birth Defects Res. C Embryo Today 69, 93–101 (2003).
Garg, A. Lipodystrophies. Am. J. Med. 108, 143–152 (2000).
Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213, 341–347 (2007).
Wang, E. A., Israel, D. I., Kelly, S. & Luxenberg, D. P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9, 57–71 (1993).
Narvaez, C. J. et al. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J. Cell. Physiol. 228, 2024–2036 (2013).
Ling, S. S. M., Chen, Y. T., Wang, J., Richards, A. M. & Liew, O. W. Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential. Int. J. Mol. Sci. 18 (2017).
Rydziel, S. et al. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J. Biol. Chem. 282, 19762–19772 (2007).
Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).
Feoktistova, M. & Leverkus, M. Programmed necrosis and necroptosis signalling. FEBS J. 282, 19–31 (2015).
Chaudhary, P. M., Jasmin, A., Eby, M. T. & Hood, L. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738–5746 (1999).
Bagnéris, C. et al. Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol. Cell 30, 620–631; (2008).
Chang, J. et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med. 15, 682–689 (2009).
Bakkar, N. & Guttridge, D. C. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol. Rev. 90, 495–511 (2010).
Chae, G. N. & Kwak, S. J. NF-kappaB is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARgamma expression. Exp. Mol. Med. 35, 431–437 (2003).
Rauch, A. & Mandrup, S. Transcriptional networks controlling stromal cell differentiation. Nat. Rev. Mol. Cell Biol. 22, 465–482 (2021).
Nakagiri, S., Murakami, A., Takada, S., Akiyama, T. & Yonehara, S. Viral FLIP enhances Wnt signaling downstream of stabilized beta-catenin, leading to control of cell growth. Mol. Cell. Biol. 25, 9249–9258 (2005).
Bagchi, D. P. & MacDougald, O. A. Wnt Signaling: From Mesenchymal Cell Fate to Lipogenesis and Other Mature Adipocyte Functions. Diabetes 70, 1419–1430 (2021).
Reznikoff, C. A., Brankow, D. W. & Heidelberger, C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33, 3231–3238 (1973).
OhYama, T., Tsukumo, S., Yajima, N., Sakamaki, K. & Yonehara, S. Reduction of thymocyte numbers in transgenic mice expressing viral FLICE-inhibitory protein in a Fas-independent manner. Microbiol. Immunol. 44, 289–297 (2000).
Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193–199 (1991).
Sakamaki, K. et al. Multiple functions of FADD in apoptosis, NF-κB-related signaling, and heart development in Xenopus embryos. Genes Cells 17, 875–896 (2012).
Kominami, K. et al. In vivo imaging of hierarchical spatiotemporal activation of caspase-8 during apoptosis. PLoS One 7, e50218 (2012).
Ikawa, M., Yamada, S., Nakanishi, T. & Okabe, M. Green fluorescent protein (GFP) as a vital marker in mammals. Curr. Top. Dev. Biol. 44, 1–20 (1999).
Nagai, H. et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc. Natl. Acad. Sci. U S A 108, E1330-1338 (2011).
Toyokuni, S., Kawaguchi, W., Akatsuka, S., Hiroyasu, M. & Hiai, H. Intermittent microwave irradiation facilitates antigen-antibody reaction in Western blot analysis. Pathol. Int. 53, 259–261 (2003).

No competing interests reported.

E8Suppl.pdf

Download PDF

Reviews received at journal
05 Jul, 2024
Reviewers agreed at journal
04 Jul, 2024
Reviews received at journal
26 Jun, 2024
Reviewers agreed at journal
26 Jun, 2024
Reviewers invited by journal
25 Jun, 2024
Editor assigned by journal
25 Jun, 2024
Editor invited by journal
10 Apr, 2024
Submission checks completed at journal
10 Apr, 2024
First submitted to journal
04 Apr, 2024

You are reading this latest preprint version

A viral FLIP protein, E8, exogenously-expressed in the mesenchymal lineage of mice leads to bone malformations, lipoatrophy, and muscular atrophy

Status:

Version 1

Abstract

Figures

Introduction

Results

Generation of E8/Cre double transgenic (E8/Cre-DTg) mice

Growth retardation of E8/Cre-DTg mice

Skeletal defects in E8/Cre-DTg mice

Abnormal phenotype in the fat tissues of E8/Cre-DTg mice

Abnormal phenotype in skeletal and cardiac muscles of E8/Cre-DTg mice

Establishment and characterization of C3H10T1/2 transfectants expressing E8

Discussion

Materials and Methods

Antibodies

Mice and cultured cells

Plasmid constructs

Generation of transgenic mice

Genotyping

Histological and immunohistochemical analyses

Micro CT analyses

Transfection of plasmid DNAs into cultured cells

Immunoblot analyses

Establishment of E8-expressing C3H10T1/2 cells

Microarray analysis

Statistical analysis

Declarations

Author Contribution

Acknowledgement

Data Availability

References

Additional Declarations

Supplementary Files

Status:

Version 1